Skip to Content

VFEND

In the US, VFEND (voriconazole systemic) is a member of the drug class azole antifungals and is used to treat Aspergillosis - Invasive, Blastomycosis, Candidemia, Coccidioidomycosis - Meningitis, Cutaneous Fungal Infection, Esophageal Candidiasis, Eumycetoma, Fungal Infection - Internal and Disseminated, Fungal Meningitis, Fungal Pneumonia, Fusariosis, Ocular Fungal Infection, Pseudoallescheriosis and Systemic Fungal Infection.

US matches:

UK matches:

Ingredient matches for VFEND

Voriconazole

Voriconazole is reported as an ingredient of VFEND in the following countries:

  • Argentina
  • Australia
  • Austria
  • Belgium
  • Bosnia & Herzegowina
  • Canada
  • Chile
  • China
  • Croatia (Hrvatska)
  • Czech Republic
  • Denmark
  • Ecuador
  • Egypt
  • Finland
  • France
  • Georgia
  • Germany
  • Greece
  • Hong Kong
  • Hungary
  • Iceland
  • Indonesia
  • Ireland
  • Israel
  • Italy
  • Japan
  • Latvia
  • Lithuania
  • Malaysia
  • Netherlands
  • New Zealand
  • Norway
  • Philippines
  • Poland
  • Romania
  • Serbia
  • Singapore
  • Slovakia
  • Slovenia
  • South Africa
  • South Korea
  • Spain
  • Sweden
  • Switzerland
  • Taiwan
  • Thailand
  • Tunisia
  • Turkey
  • United Kingdom
  • United States

International Drug Name Search

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide